These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19283492)

  • 1. Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin.
    Hirlekar R; Kadam V
    AAPS PharmSciTech; 2009; 10(1):276-81. PubMed ID: 19283492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility.
    Hirlekar RS; Sonawane SN; Kadam VJ
    AAPS PharmSciTech; 2009; 10(3):858-63. PubMed ID: 19562489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Irbesartan Nanocrystals by High Shear Homogenisation and Ultra-Probe Sonication for Improved Dissolution Rate.
    Sridhar K; Rahman H; Sosnik A; Mukherjee U; Natarajan T; Siram K; Krishnamoorthy B
    Curr Drug Deliv; 2016; 13(5):688-97. PubMed ID: 26563944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
    AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of β -cyclodextrin from pH and thermo stable Cyclodextrin Glycosyl Transferase, obtained from Arthrobacter mysorens and its evaluation as a drug carrier for Irbesartan.
    Rajesh Y; Narayanan K; Reddy MS; Bhaskar VK; Shenoy GG; Subrahmanyam VM; Rao JV
    Curr Drug Deliv; 2015; 12(4):444-53. PubMed ID: 25901452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.
    Patel R; Purohit N
    AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs.
    Zhang L; Zhu W; Lin Q; Han J; Jiang L; Zhang Y
    Int J Nanomedicine; 2015; 10():3291-302. PubMed ID: 25995635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
    Bhargava S; Agrawal GP
    Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Soluplus
    Soe HMSH; Sripetch S; Loftsson T; Stefánsson E; Jansook P
    Pharm Dev Technol; 2022 Jan; 27(1):9-18. PubMed ID: 34895036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation.
    Mukne AP; Nagarsenker MS
    AAPS PharmSciTech; 2004 Mar; 5(1):E19. PubMed ID: 15198540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.